Description
Ophthalmic solution containing sodium hyaluronate which, thanks to its muco-mimetic and pseudo-plastic properties, distributes uniformly on the ocular surface, forming a protective viscoelastic bandage. In this way, by exerting a mechanical action (barrier effect), Idroflog stabilizes the tear film and reduces the friction caused by eye movements and blinking, protects the eye surface by promoting repair processes consequent to suffering of the corneal epithelial cells due to hyposecretion of the tear film. In fact, in cases where the glands responsible for tear film secretion reduce their normal activity due to various factors, the corneal surface remains more exposed to external insults. These, over time, cause a malfunction of the corneal epithelial cells with an associated risk of irritating inflammatory processes. The application of the Idroflog bandage protects the corneal surface from exposure to external insults and, thanks to the ancillary action of hydrocortisone sodium phosphate (a low-dose corticosteroid agent with low anti-inflammatory power and short duration of action), helps prevent the risk of any recurrence of inflammatory phenomena. Idroflog is intended for limited use over time and in any case under the direct supervision of a specialist doctor. Finally, Idroflog, thanks to its particular saline composition, restores and maintains at physiological levels the concentrations of important ions, such as sodium, potassium and magnesium, essential for the well-being of the ocular surface. The device does not contain preservatives.

Composition
Sodium hyaluronate 2 mg/ml, hydrocortisone sodium phosphate 10 mcg/ml, trisodium citrate, sodium chloride, potassium chloride, magnesium chloride, dibasic sodium phosphate, monobasic sodium phosphate, water for injections.

Directions for use
Idroflog should be dosed individually according to your condition and based on your ophthalmologist's recommendations. In general, instill 1-2 drops of the solution into the conjunctival sac of the eye to be treated, 2-4 times a day. The total duration of treatment is 2-6 months but must be specifically determined by the specialist doctor and in any case under their direct supervision (a follow-up every 30-45 days is recommended).
How to apply: detach a single vial from the strip. Remove the top tab by twisting it. Instill 1-2 drops into the conjunctival sac, letting them fall from above. Idroflog can also be used while wearing contact lenses.

Warnings
Due to its viscoelastic properties, the product may cause temporary blurred vision upon installation. Wait until this effect subsides before driving vehicles or operating machinery.
Idroflog is for external use only. It should not be used immediately before administering curative medicines, and within twenty minutes after applying any topical drug therapy. If symptoms worsen during treatment, contact a doctor as soon as possible. Prolonged use may cause problems: the total duration of treatment must be determined by the ophthalmologist. If an inflammatory process is already underway, the specialist doctor will decide on the appropriate anti-inflammatory therapy to restore the physiological conditions of the ocular surface. To reduce the risk of contamination during use, the aluminum pouch should only be opened immediately before using the product. Avoid direct contact of the tip of the vial with fingers, the eye, or any other surface. In rare cases, slight blurred vision has been observed upon instillation, which is due to the viscosity of the solution. A slight burning sensation may occur during instillation. However, this sensation is destined to disappear. Contact your ophthalmologist if symptoms persist. Adhering to the instructions in the leaflet reduces the risk of side effects. The product is for single use: after the first use, discard the vial even if it contains any residual solution.

Storage
Store at a temperature between 2°C and 25°C.

Format
Pack containing 15 vials of 0.5 ml.